Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...

Due to its innovative mechanism and extended dosing schedule, Lenacapavir has been described as a pathbreaking advancement in HIV care and is being heralded as an early vaccine-like innovation in ...

ATLANTA - Lenacapavir, a new injectable drug for HIV prevention, is being hailed by Emory University medical experts as a breakthrough in the fight against the virus. The drug offers a long-acting ...

Emory University medical experts say lenacapavir could be a gamechanger in the battle against HIV and they played a critical role in the study. US to send $1.25 billion in weapons to Ukraine ...